Production of influenza virus in cell cultures for vaccine preparation

Advances in Experimental Medicine and Biology

Volumn 397, Issue , 1996, Pages 141-151

  Merten, O W ^a   Hannoun, C ^a   Manuguerra, J C ^a   Ventre, F ^a   Petres, S ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE RESPIRATORY SYNCYTIAL VIRUS; EQUIDAE; INFLUENZA VIRUS;

VACCINE;

ANIMAL CELL; ANTIBODY PRODUCTION; CELL VIABILITY; CONFERENCE PAPER; DRUG SYNTHESIS; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIROGENESIS; VIRUS CULTURE; VIRUS INACTIVATION; VIRUS PURIFICATION; VIRUS STRAIN;

EID: 0030042880     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1382-1_19     Document Type: Article

References (14)

1. Bödeker, B.G.D., Newcomb, R., Yuan, P., Braufman, A., and Kelsey, W., 1994, Production of recombinant factor VIII from perfusion cultures: I. Large- scale fermentation. In: Spier, R.E., Griffiths, J.B., and Berthold, W. (eds.): Animal Cell Technology: Products of Today, Prospects for Tomorrow, pp. 580-583, Butterworth-Heinemann, Oxford.
2. Capstick P.B., Telling, R.C., Chapman, W.G., and Stewart, D.L., 1962, Growth of a cloned strain of hamster kidney cells in suspended cultures and their suceptibility to the virus of foot-and-mouth disease. Nature 195: 1163-1164.
3. Merten, O.-W., Kierulff, J.V., Castignolles, N., and Perrin, P., 1994, Evaluation of the new erum-free medium (MDSS2) for the production of different biologicals: Use of various cell lines. Cytotechnology 14: 47-59.
4. Merten, O.-W., Petres, S., and Couvé , E., 1995, A simple serum-free freezing medium for serum free cultured cells. Biologicals 23: 185-189.
5. Montagnon, B., Vincent-Falquet, J.C., and Fanget, B., 1984. Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results. Develop. biol. Standard. 55: 37-42.
6. Oxford J.S., Corcoran T., Knott R., Bates J., Bartolomei O., Major D., Newman R.W., Yates P., Robertson J.S., Webster R.G. et al., 1987, Serological studies with influenza A(H1N1) viruses cultivated in eggs or in a canine kidney cell line (MDCK), Bull. WHO 65: 181-187.
7. Oxford J.S., Corcoran T., Bootman J., Major D., Yates P., Robertson J.S. and Schild G.C., 1991, Direct isolation in eggs of influenza A(H1N1) and B viruses with hemagglutinins of different antigenic and amino-acid composition. J. Gen. Virol. 72: 185-189.
8. Perrin, P, Madhusudana, S., Gontier-Jallet, C., Petres, S., Tordo, N., and Merten, O.-W., 1995 An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Vaccine 13: 1244-1250.
9. Pyhala R., Pyhala L., Valle M. and Aho K., 1987, Egg-grown and tissue culture grown variants of influenza A(H3N2) virus with special attention to their use as antigens in seroepidemiology. Epidem. Inf. 99: 745-753.
10. Radlett, P.J., 1987, The use of BHK suspension cells for the production of foot and mouth disease vaccines. In: Fiechter, A. (ed.): Advances in Biochemical Engineering/Biotechnology, Vol. 34, pp. 129-146, Springer- Verlag, Berlin-Heidelberg.
11. Robertson J.S., Bootman J.S., Newman R., Oxford J.S., Danoels R.S., Webster R.G. and Schild G.C., 1987, Structural changes in the hemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology 160: 31-37.
12. Rocha, E.P., Xo, X., Hau, H.E., Allen, J.R., Regnery, H., and Cox, N., 1993, Comparison of 10 influenza A(H1N1 and H3N2) hemagglutinin sequences obtained directly from clinical specimens to those of MDCK-cell and egg- grown viruses. J. Gen. Virol. 74: 2513-2518.
13. Wang M.L., Katz J.M. and Webster R.G., 1989, Extensive heterogeneity in the hemagglutinin of egg-grown influenza viruses from different patients. Virology 171: 275-279.
14. Wood J.M., Oxford J.S., Dunleavy U., Newman R.W., Major D. and Robertson J.S., 1989, Influenza A(H1N1) vaccine efficacy in animal models is influenced by two amino-acid substitutions in the hemaglutinin molecule. Virology 171: 214-221.